We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

THE BINDING SITE

Engages in the research, development, manufacture, and distribution of immunodiagnostic assays, as wel as specialized... read more Featured Products: More products

Download Mobile App





Binding Site Exhibits Special Protein Analyzer Optilite at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 12 Apr 2022

Binding Site (Birmingham, UK) participated in the IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine (EUROMEDLAB) hosted by the German Society of Clinical Chemistry and Laboratory Medicine (DGKL), one of the oldest national societies devoted to clinical chemistry and laboratory medicine. More...

At EUROMEDLAB 2022, Binding Site exhibited its special protein analyzer, Optilite which is the perfect solution for the modern protein laboratory. Integrating powerful technology and intelligent software, Optilite is fully optimized for protein analysis to create simplicity from complex analytical processes. The true benchtop analyzer and assays work in perfect harmony, giving labs complete peace of mind and the freedom to allocate their time more effectively.

Optilite is specifically designed for laboratory workflow optimization. Its continuous loading of samples, reagents, and consumables plus automatic re-dilution to end result enable labs to maximize test throughput while minimizing hands-on time. A comprehensive menu of special protein assays, including Binding Site’s Freelite test, is available. With a compact benchtop design, Optilite is quick to install, easy to maintain, and is equipped with full LIS connectivity and automatic barcode recognition for full traceability. Unique to Optilite is a robust antigen excess protection system with three detection methods, thereby ensuring accurate and reliable results.

Related Links:
Binding Site 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.